http://media.peerviewpress.com/000136/podcast/pvi/xml/pulmonology_audio.xml Fri, 11 Dec 2009 10:50:00 -0500 PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/Pulmonology/podcast_PulmonologyCME-CNE-CPE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Pulmonology no PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://podcast.peerviewpress.com/Pulmonology/PPVNE06250e28.mp3 http://podcast.peerviewpress.com/Pulmonology/Audio_Podcast_Audio_PPVNE06250.mp3 Thu, 10 Dec 2009 10:43:46 -0500 Science, Medicine no 00:30:16 NSCLC, lung cancer, maintenance, pemetrexed, cetuximab, erlotinib, targeted, cytotoxic, JMEN, treatment break PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Pulmonology/PPVNE06250CMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PPVNE06250_Podcast_QAApp_101209.pdf Thu, 10 Dec 2009 10:43:24 -0500 Science, Medicine no 00:00:00 NSCLC, lung cancer, maintenance, pemetrexed, cetuximab, erlotinib, targeted, cytotoxic, JMEN, treatment break PVI, PeerView Institute for Medical Education In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the rationale for studying maintenance therapy in NSCLC settings and the clinical implications of new data on the maintenance use of active cytotoxic agents and targeted therapy in patients with advanced NSCLC. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the rationale for studying maintenance therapy in NSCLC settings and the clinical implications of new data on the maintenance use of active cytotoxic agents and targeted therapy in patients with advanced NSCLC. http://podcast.peerviewpress.com/Pulmonology/PPVNE05904r67.mp3 http://podcast.peerviewpress.com/Pulmonology/PPVNE05904r67.mp3 Fri, 25 Sep 2009 14:51:18 -0400 Science, Medicine no 00:14:52 maintenance, NSCLC, lung cancer, cytotoxic, JMEN, Fidias, nonsquamous, squamous, histology, erlotinib, advanced PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Pulmonology/PPVNE05904CMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PPVNE05904CMEinfo.pdf Fri, 25 Sep 2009 14:51:15 -0400 Science, Medicine no 00:00:00 maintenance, NSCLC, lung cancer, cytotoxic, JMEN, Fidias, nonsquamous, squamous, histology, erlotinib, advanced PVI, PeerView Institute for Medical Education In this activity, experts discuss the latest clinical trial data on the use of maintenance therapy, the clinical role of biomarkers in selecting the most appropriate therapy, and the potential of novel agents and combination strategies for advanced lung cancer. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts discuss the latest clinical trial data on the use of maintenance therapy, the clinical role of biomarkers in selecting the most appropriate therapy, and the potential of novel agents and combination strategies for advanced lung cancer. http://podcast.peerviewpress.com/Pulmonology/PA05722FCs143.mp3 http://podcast.peerviewpress.com/Pulmonology/PA05722FCs143.mp3 Tue, 08 Sep 2009 15:09:27 -0400 Science, Medicine no 00:34:29 NSCLC, lung cancer, histology, PFS, pemetrexed, nonsquamous, squamous, EGFR, JMEN, SATURN, Fidias PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Pulmonology/PA05722FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA05722FCCMEinfo.pdf Tue, 08 Sep 2009 15:09:26 -0400 Science, Medicine no 00:00:00 NSCLC, lung cancer, histology, PFS, pemetrexed, nonsquamous, squamous, EGFR, JMEN, SATURN, Fidias PVI, PeerView Institute for Medical Education In this educational activity, 3 clinical experts in NSCLC discuss the current state and potential future directions of targeted therapy for the treatment of this disease in its advanced stages. Highlights of this discussion include the integration of these therapies into first-line treatment and maintenance regimens for advanced NSCLC, emerging molecular targeted agents for recurrent/refractory disease, and the application of predictive and prognostic markers as well as other patient-specific and disease-related characteristics for treatment selection in patients with this malignancy. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this educational activity, 3 clinical experts in NSCLC discuss the current state and potential future directions of targeted therapy for the treatment of this disease in its advanced stages. Highlights of this discussion include the integration of these therapies into first-line treatment and maintenance regimens for advanced NSCLC, emerging molecular targeted agents for recurrent/refractory disease, and the application of predictive and prognostic markers as well as other patient-specific and disease-related characteristics for treatment selection in patients with this malignancy. http://podcast.peerviewpress.com/Pulmonology/PA05538FCe20.mp3 http://podcast.peerviewpress.com/Pulmonology/PA05538FCe20.mp3 Tue, 11 Aug 2009 15:26:34 -0400 Science, Medicine no 00:34:43 non small cell lung cancer, NSCLC, gemcitabine, bevacizumab, cisplatin, pemetrexed, FLEX, erlotinib PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Pulmonology/PA05538FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA05538FCCMEinfo.pdf Tue, 11 Aug 2009 15:26:31 -0400 Science, Medicine no 00:00:00 non small cell lung cancer, NSCLC, gemcitabine, bevacizumab, cisplatin, pemetrexed, FLEX, erlotinib PVI, PeerView Institute for Medical Education In this activity, an expert in PAH discusses signs and symptoms, diagnostic procedures, and optimal treatment approaches, including combination strategies, in patients with the condition. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in PAH discusses signs and symptoms, diagnostic procedures, and optimal treatment approaches, including combination strategies, in patients with the condition. http://podcast.peerviewpress.com/Pulmonology/PA04897FCn210.mp3 http://podcast.peerviewpress.com/Pulmonology/PA04897FCn210.mp3 Wed, 17 Jun 2009 15:04:03 -0400 Science, Medicine no 00:24:23 pulmonary arterial hypertension, PAH PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/Pulmonology/PA04897FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA04897FCCMEinfo.pdf Wed, 17 Jun 2009 15:04:01 -0400 Science, Medicine no 00:00:00 pulmonary arterial hypertension, PAH PVI, PeerView Institute for Medical Education In this activity, experts in the management of COPD debate on how to optimize current management of COPD and what to expect from emerging therapies. They also discuss the most up-to-date evidence on the use of combination strategies and various formulation options. Finally, they offer their own insights into the value of early intervention and approaches to patients with COPD who continue to smoke. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of COPD debate on how to optimize current management of COPD and what to expect from emerging therapies. They also discuss the most up-to-date evidence on the use of combination strategies and various formulation options. Finally, they offer their own insights into the value of early intervention and approaches to patients with COPD who continue to smoke. http://podcast.peerviewpress.com/Pulmonology/PA05116FCe022.mp3 http://podcast.peerviewpress.com/Pulmonology/PA05116FCe022.mp3 Tue, 25 Nov 2008 09:52:08 -0500 Science, Medicine no 00:31:41 COPD, chronic obstructive pulmonary disease, LABA, LAMA, long-acting bronchodilators, PDE-IV inhibitors, formoterol, tiotropium, asthma PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Pulmonology/PA05116FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA05116FCCMEinfo.pdf Tue, 25 Nov 2008 09:51:08 -0500 Science, Medicine no 00:00:00 COPD, chronic obstructive pulmonary disease, LABA, LAMA, long-acting bronchodilators, PDE-IV inhibitors, formoterol, tiotropium, asthma PVI, PeerView Institute for Medical Education This CME activity reviews the risk factors of AAT deficiency and strategies to prevent disease progression. Strategies for improving detection and management of the disorder are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. This CME activity reviews the risk factors of AAT deficiency and strategies to prevent disease progression. Strategies for improving detection and management of the disorder are also highlighted. http://podcast.peerviewpress.com/Pulmonology/PA04233FCr400.mp3 http://podcast.peerviewpress.com/Pulmonology/PA04233FCr400.mp3 Tue, 26 Aug 2008 16:29:29 -0400 Science no 00:23:51 alpha1-Antitrypsin, AAT, proteases, emphysema, bronchiectasis, panniculitis, COPD, lung cancer, augmentation, alpha-1 proteinase inhibitor (human) PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Pulmonology/PA04233FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA04233FCCMEinfo.pdf Tue, 26 Aug 2008 16:29:21 -0400 Science no 00:00:00 alpha1-Antitrypsin, AAT, proteases, emphysema, bronchiectasis, panniculitis, COPD, lung cancer, augmentation, alpha-1 proteinase inhibitor (human) PVI, PeerView Institute for Medical Education In this program, an expert will provide an update on the latest guideline recommendations for managing asthma, particularly as they relate to the primary care setting, and discuss the implications for clinical practice. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this program, an expert will provide an update on the latest guideline recommendations for managing asthma, particularly as they relate to the primary care setting, and discuss the implications for clinical practice. http://podcast.peerviewpress.com/Pulmonology/PA04191FCn176.mp3 http://podcast.peerviewpress.com/Pulmonology/PA04191FCn176.mp3 Tue, 04 Mar 2008 17:08:09 -0500 Science no 00:27:09 Asthma,EPR3,NAEPP,lung,ICS,LABA,omalizumab,IgE,FEV,allergies,allergy,anaphylaxis,nebulizers PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/Pulmonology/PA04191FCCMECEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA04191FCCMECEinfo.pdf Tue, 04 Mar 2008 17:08:05 -0500 Science no 00:00:00 Asthma,EPR3,NAEPP,lung,ICS,LABA,omalizumab,IgE,FEV,allergies,allergy,anaphylaxis,nebulizers PVI, PeerView Institute for Medical Education The latest data and guidelines are applied to the control of asthma in the clinic through instructive case studies presented by Dr. Marcus. Please be sure to view the accompanying (PDF) file for full CME/CE information. The latest data and guidelines are applied to the control of asthma in the clinic through instructive case studies presented by Dr. Marcus. http://podcast.peerviewpress.com/Pulmonology/PA03462FC2p114.mp3 http://podcast.peerviewpress.com/Pulmonology/PA03462FC2p114.mp3 Mon, 03 Mar 2008 15:46:42 -0500 Science no 00:37:54 Asthma, COPD, IgE, pulmonology, EPR-3, FEV1, omalizumab, anaphylaxis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/Pulmonology/PA03462FC2CMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA03462FC2CMEinfo.pdf Mon, 03 Mar 2008 15:45:42 -0500 Science no 00:00:00 Asthma, COPD, IgE, pulmonology, EPR-3, FEV1, omalizumab, anaphylaxis PVI, PeerView Institute for Medical Education In this CME activity, experts in the treatment of COPD present recent data on current and emerging agents used to treat this disease. Survival benefits and safety of these agents are also discussed. Current and emerging delivery systems are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of COPD present recent data on current and emerging agents used to treat this disease. Survival benefits and safety of these agents are also discussed. Current and emerging delivery systems are also highlighted. http://podcast.peerviewpress.com/Pulmonology/PA04161FCr358.mp3 http://podcast.peerviewpress.com/Pulmonology/PA04161FCr358.mp3 Wed, 20 Feb 2008 15:52:30 -0500 Science no 00:24:35 COPD, chronic obstructive pulmonary disease, bronchitis, anticholinergics, short-acting beta-agonists, long-acting beta-agonist, beta adrenoceptor agonists, albuterol, levabuterol, ipratropium bromide PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/Pulmonology/PA04161FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA04161FCCMEinfo.pdf Wed, 20 Feb 2008 15:52:02 -0500 Science no 00:00:00 COPD, chronic obstructive pulmonary disease, bronchitis, anticholinergics, short-acting beta-agonists, long-acting beta-agonist, beta adrenoceptor agonists, albuterol, levabuterol, ipratropium bromide PVI, PeerView Institute for Medical Education In this program, an expert will discuss how to diagnose, monitor, and treat patients with difficult-to-control asthma. Patient scenarios are used to illustrate how to apply current evidence and latest treatment guidelines to everyday practice. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this program, an expert will discuss how to diagnose, monitor, and treat patients with difficult-to-control asthma. Patient scenarios are used to illustrate how to apply current evidence and latest treatment guidelines to everyday practice. http://podcast.peerviewpress.com/Pulmonology/PA03778FCp131.mp3 http://podcast.peerviewpress.com/Pulmonology/PA03778FCp131.mp3 Wed, 09 Jan 2008 16:35:33 -0500 Science no 00:24:47 Asthma, pulmonology PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/Pulmonology/PA03788FCCMEinfo.pdf http://podcast.peerviewpress.com/Pulmonology/PA03788FCCMEinfo.pdf Wed, 09 Jan 2008 16:35:30 -0500 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Pulmonology